1. Phase I and II trial of 4′-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia;Arlin;Cancer Res.,1980
2. Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide;Baguley;Cancer Res.,1984
3. Cytotoxicity and interaction of amsacrine derivatives with topoisomerase II: role of the 1′ substitute on the aniline nucleus;Rene;Bull. Cancer,1997
4. Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugs;Finlay;Eur. J. Cancer Clin. Oncol.,1989
5. Phase II study of the amsacrine analogue CI-921 (NSC 343499) in non-small cell lung cancer;Harvey;Eur. J. Cancer,1991